Head and Neck Cancers

Latest News

conceptual image of head and neck against yellow background
Stopping ICIs at 1 or 2 Years May Not Compromise Survival in HNSCC

September 11th 2024

This retrospective, population-based study shows strong efficacy across multiple patient subgroups and different lines of therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma.

Patients With Postoperative Delirium May Benefit From a Holistic Management Approach
Patients With Postoperative Delirium May Benefit From a Holistic Management Approach

August 18th 2024

Adding Pembrolizumab to Chemo Demonstrates Antitumor Activity in Head and Neck Squamous Cell Carcinoma
Adding Pembrolizumab to Chemo Demonstrates Antitumor Activity in Head and Neck Squamous Cell Carcinoma

August 12th 2024

Ozuriftamab Vedotin Receives Fast Track Designation for Recurrent/Metastatic HNSCC
Ozuriftamab Vedotin Receives Fast Track Designation for Recurrent/Metastatic HNSCC

August 9th 2024

Cisplatin-Based Chemotherapy May Affect Hearing in Cancer Survivors
Cisplatin-Based Chemotherapy May Affect Hearing in Cancer Survivors

July 22nd 2024

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.